We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
EFC
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Quest Diagnostics
DGX
$22.9B
| – | – |
-1,386
| Closed | -$241K |
|
252
Definitive Healthcare
DH
$76.5M
| – | – |
-41,769
| Closed | -$120K |
|
253
DHT Holdings
DHT
$2.97B
| – | – |
-27,597
| Closed | -$337K |
|
254
HF Sinclair
DINO
$16.5B
| – | – |
-7,793
| Closed | -$359K |
|
|
255
Delek US
DK
$4.12B
| – | – |
-24,407
| Closed | -$724K |
|
256
dLocal
DLO
$4.35B
| – | – |
-16,889
| Closed | -$239K |
|
257
DNOW Inc
DNOW
$2.6B
| – | – |
-25,779
| Closed | -$342K |
|
258
Healthpeak Properties
DOC
$15.6B
| – | – |
-15,429
| Closed | -$248K |
|
259
Dole
DOLE
$1.33B
| – | – |
-11,683
| Closed | -$175K |
|
|
DOO
260
Bombardier Recreational Products
DOO
$4.38B
| – | – |
-6,216
| Closed | -$440K |
|
261
Diamondrock Hospitality Co
DRH
$2.65B
| – | – |
-29,168
| Closed | -$261K |
|
262
Leonardo DRS
DRS
$12.1B
| – | – |
-12,693
| Closed | -$433K |
|
263
Descartes Systems
DSGX
$6.08B
| – | – |
-2,547
| Closed | -$223K |
|
264
Duolingo
DUOL
$5.81B
| – | – |
-1,319
| Closed | -$231K |
|
265
DaVita
DVA
$15.2B
| – | – |
-3,744
| Closed | -$425K |
|
266
DexCom
DXCM
$28.8B
| – | – |
-3,131
| Closed | -$208K |
|
|
267
Brinker International
EAT
$8.27B
| – | – |
-4,520
| Closed | -$649K |
|
268
Ecolab
ECL
$74.4B
| – | – |
-946
| Closed | -$248K |
|
|
ECO
269
Okeanis Eco Tankers
ECO
$2.23B
| – | – |
-7,696
| Closed | -$260K |
|
270
Euronet Worldwide
EEFT
$3.02B
| – | – |
-2,677
| Closed | -$204K |
|
271
Encompass Health
EHC
$11.1B
| – | – |
-2,483
| Closed | -$264K |
|
272
eHealth
EHTH
$46M
| – | – |
-28,497
| Closed | -$131K |
|
273
Equitable Holdings
EQH
$13.2B
| – | – |
-4,279
| Closed | -$204K |
|
274
ESAB
ESAB
$5.34B
| – | – |
-2,075
| Closed | -$232K |
|
275
ESCO Technologies
ESE
$8.61B
| – | – |
-1,608
| Closed | -$314K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
T
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.